2016

Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single centre in Turkey

Background/aim: The aim of this study was to evaluate the clinical outcomes and identify the predictors of mortality in peritonealdialysis patients.Materials and methods: Medical records of all incident peritoneal dialysis (PD) patients followed up between January 2011 and May2019 were reviewed retrospectively. All patients were followed up until death, renal transplantation, transfer to haemodialysis or theend of the study.Results: A total of 242 patients were included in the study. The incidence of peritonitis was 0.18 (ranging from 0 to 14.9) episodes perpatient year. Death occurred in 28% (n: 68) of cases. Age, diabetes mellitus, malignancy and refractory heart failure were independentrisk factors for all-cause mortality according to multivariate analysis. The presence of comorbid disease and diabetes mellitus and patientsaged > 65 years were associated with increased risk of mortality and decreased patient survival. Peritonitis history was associated withincreased risk of mortality. Between peritonitis and peritonitis-free group, there was no significant difference in Kaplan-Meier curvesin terms of patient survival.Conclusion: This is the first study to define 9-year mortality predictors in PD patients in our centre. Although peritonitis is the mostfeared complication of PD, our study showed that peritonitis did not reduce patient survival.

PDF

___

1. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R et al. A global overview of the impact of peritoneal dialysis first or favored policies: an Opinion. Peritoneal Dialysis International 2015; 35 (4): 406-420. doi: 10.3747/pdi.2013.00204
2. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrology Dialysis Transplantation 2005; 20 (12): 2587-2593.
3. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrology Dialysis Transplantation 2001;16 (2): 341-347.
4. Flayou K, Ouzeddoun N, Bayahia R, Rhou H, Benamar L. Mechanical complications of continuous ambulatory peritoneal dialysis: experience at the Ibn Sina University Hospital. Saudi Journal of Kidney Diseases and Transplantation 2016; 27 (1): 107-110.
5. Lee JH, Park SH, Lim JH, Park YJ, Kim SU et al. Impact of dialysis modality on technique survival in end-stage renal disease patients. Korean Journal of Internal Medicine 2016; 31 (1): 106-115.
6. Mizuno M, Ito Y, Suzuki Y, Sakata F, Saka Y et al. Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry. Clinical and Experimental Nephrology 2016; 20 (6): 960-971.
7. Peng Y, Yang X, Chen W, Yu XQ. Association between timing of peritoneal dialysis initiation and mortality in end-stage renal disease. Chronic Diseases and Translational Medicine 2018;5 (1): 37-43.
8. Lasfar LB, Guedri Y, Zellama D, El Meknassi I, Azzebi A et al. Long-term clinical outcomes of peritoneal dialysis patients: 10-year experience of a single unit from Tunisia. Saudi Journal Kidney Disease Transplantation 2019;30 (2): 451-461.
9. Vikrant S. Long-term clinical outcomes of peritoneal dialysis patients: 9-year experience of a single center from north India. Peritoneal Dialysis International 2014; 34 (4): 426-433.
10. Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N et al. Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrology 2009;10: 3.
11. Gray NA, Grace BS, McDonald SP. Peritoneal dialysis in rural Australia. BMC Nephrology 2013;14: 278. doi: 10.1186/1471- 2369-14-278
12. Süleymanlar G, Ateş K, Seyahi N. Registry of the Nephrology, Dialysis and Transplantation in Turkey, Registry 2017. Ankara, Turkey: Miki press; 2018.
13. Erek E, Süleymanlar G, Serdengeçti K, Altıparmak MR, Seyahi N et al. Registry of the Nephrology, Dialysis and Transplantation in Turkey. İstanbul, Turkey: Turkish Society of Nephrology; 2008.
14. Shahbaz H, Gupta M. Creatinine Clearance. St Petersburg, FL, USA: StatPearls Publishing; 2019.
15. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Peritoneal Dialysis International 2016;36 (5): 481- 508.
16. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Peritoneal Dialysis International 2011; 31 (6): 614-630.
17. Sakacı T, Ahbap E, Koc Y, Basturk T, Ucar ZA et al. Clinical outcomes and mortality in elderly peritoneal dialysis patients. Clinics (Sao Paulo) 2015; 70 (5): 363-368. doi: 10.6061/ clinics/2015(05)10
18. Abe M, Hamano T, Hoshino J, Wada A, Nakai S et al. Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study. Scientific Reports 2019; 9 (1): 3967. doi: 10.1038/s41598-019-40692-6
19. Remón-Rodríguez C, Quirós-Ganga P, Portolés-Pérez J, Gómez-Roldán C, Miguel-Carrasco A et al. Grupo Cooperativo Registros Españoles de Diálisis Peritoneal. [Results of the cooperative study of Spanish peritoneal dialysis registries: analysis of 12 years of follow-up]. Nefrologia 2014; 34 (1): 18-33.
20. Grossekettler L, Schmack B, Meyer K, Brockmann C, Wanninger R et al. Peritoneal dialysis as therapeutic option in heart failure patients. ESC Heart Failure 2019;6 (2): 271-279.
21. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysisassociated peritonitis in Scotland (1999-2002). Nephrology Dialysis Transplantation 2004; 19 (10): 2584-2591.
22. Teixeira JP, Combs SA, Teitelbaum I. Peritoneal dialysis: update on patient survival. Clinical Nephrology 2015;83 (1): 1-10.
23. Ye H, Zhou Q, Fan L, Guo Q, Mao H et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrology 2017;18 (1): 186.
24. Mujais S, Story K. Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney International Supplementary 2006; 103: S21-S26.
25. Tsujikawa H, Tanaka S, Matsukuma Y, Kanai H, Torisu K et al. Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis. PLoS One 2019; 14 (3): e0213922.
26. Tabibi H, As’habi A, Najafi I, Hedayati M. Prevalence of dynapenic obesity and sarcopenic obesity and their associations with cardiovascular disease risk factors in peritoneal dialysis patients. Kidney Research and Clinical Practice 2018; 37 (4): 404-413.
27. Wang H, Tian J, Du F, Wang T. Effect of peritoneal transport characteristics on clinical outcome in nondiabetic and diabetic nephropathy patients with peritoneal dialysis. Iranian Journal of Kidney Disease 2019; 13 (1): 56-66.